Adamis Pharmaceuticals reported 15.03K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adamis Pharmaceuticals ADMP:US 15.03K 20
Adma Biologics ADMA:US $ 0.02M 0M
Brainstorm Cell Therapeutics BCLI:US $ 0.01M 0M
Cara Therapeutics CARA:US $ 53K 0
Cerulean Pharma CERU:US $ 0.01M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Redhill Biopharma RDHL:US $ 1.51M 0.01M